EPRX
Price
$5.39
Change
+$0.03 (+0.56%)
Updated
Sep 5 closing price
Capitalization
191.82M
58 days until earnings call
IOVA
Price
$2.49
Change
+$0.29 (+13.18%)
Updated
Sep 5 closing price
Capitalization
901.02M
59 days until earnings call
Interact to see
Advertisement

EPRX vs IOVA

Header iconEPRX vs IOVA Comparison
Open Charts EPRX vs IOVABanner chart's image
Eupraxia Pharmaceuticals
Price$5.39
Change+$0.03 (+0.56%)
Volume$30.3K
Capitalization191.82M
Iovance Biotherapeutics
Price$2.49
Change+$0.29 (+13.18%)
Volume$15.23M
Capitalization901.02M
EPRX vs IOVA Comparison Chart in %
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. IOVA commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and IOVA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (EPRX: $5.39 vs. IOVA: $2.49)
Brand notoriety: EPRX and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 261% vs. IOVA: 94%
Market capitalization -- EPRX: $191.82M vs. IOVA: $901.02M
EPRX [@Biotechnology] is valued at $191.82M. IOVA’s [@Biotechnology] market capitalization is $901.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileIOVA’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • IOVA’s FA Score: 1 green, 4 red.
According to our system of comparison, IOVA is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 5 TA indicator(s) are bullish while IOVA’s TA Score has 5 bullish TA indicator(s).

  • EPRX’s TA Score: 5 bullish, 4 bearish.
  • IOVA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than EPRX.

Price Growth

EPRX (@Biotechnology) experienced а +0.56% price change this week, while IOVA (@Biotechnology) price change was +11.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

EPRX is expected to report earnings on Nov 05, 2025.

IOVA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOVA($901M) has a higher market cap than EPRX($192M). EPRX YTD gains are higher at: 70.032 vs. IOVA (-66.351). EPRX has higher annual earnings (EBITDA): -28.83M vs. IOVA (-364.8M). IOVA has more cash in the bank: 301M vs. EPRX (19.8M). EPRX has less debt than IOVA: EPRX (35.1K) vs IOVA (53.2M). IOVA has higher revenues than EPRX: IOVA (242M) vs EPRX (0).
EPRXIOVAEPRX / IOVA
Capitalization192M901M21%
EBITDA-28.83M-364.8M8%
Gain YTD70.032-66.351-106%
P/E RatioN/AN/A-
Revenue0242M-
Total Cash19.8M301M7%
Total Debt35.1K53.2M0%
FUNDAMENTALS RATINGS
IOVA: Fundamental Ratings
IOVA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
24

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPRXIOVA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
43%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
42%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
39%
Bullish Trend 5 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASCZX11.290.14
+1.26%
Alger Small Cap Growth Z
PSGIX23.390.12
+0.52%
BlackRock Advantage Small Cap Gr Instl
RPMIX9.710.03
+0.31%
Royce Small-Cap Fund Instl
AVUAX16.820.04
+0.24%
American Century Mid Cap Value I
SRIAX14.08-0.06
-0.42%
Gabelli SRI A

EPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with NAGE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then NAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+0.56%
NAGE - EPRX
34%
Loosely correlated
+0.97%
ACAD - EPRX
28%
Poorly correlated
-0.94%
MDGL - EPRX
26%
Poorly correlated
+0.39%
IOVA - EPRX
26%
Poorly correlated
+13.18%
CCCC - EPRX
26%
Poorly correlated
+1.87%
More